Your browser doesn't support javascript.
loading
The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents.
Spriano, Filippo; Chung, Elaine Yee Lin; Gaudio, Eugenio; Tarantelli, Chiara; Cascione, Luciano; Napoli, Sara; Jessen, Katti; Carrassa, Laura; Priebe, Valdemar; Sartori, Giulio; Graham, Garrett; Selvanathan, Saravana P; Cavalli, Andrea; Rinaldi, Andrea; Kwee, Ivo; Testoni, Monica; Genini, Davide; Ye, B Hilda; Zucca, Emanuele; Stathis, Anastasios; Lannutti, Brian; Toretsky, Jeffrey A; Bertoni, Francesco.
Afiliación
  • Spriano F; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Chung EYL; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Gaudio E; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Tarantelli C; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Cascione L; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Napoli S; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Jessen K; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Carrassa L; Oncternal Therapeutics, San Diego, California.
  • Priebe V; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Sartori G; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Graham G; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Selvanathan SP; Departments of Oncology and Pediatrics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
  • Cavalli A; Departments of Oncology and Pediatrics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
  • Rinaldi A; Università della Svizzera italiana, Institute of Biomedical Research, Bellinzona, Switzerland.
  • Kwee I; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Testoni M; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Genini D; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Ye BH; Dalle Molle Institute for Artificial Intelligence, Manno, Switzerland.
  • Zucca E; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Stathis A; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Lannutti B; Department of Cell Biology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, New York.
  • Toretsky JA; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Bertoni F; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Clin Cancer Res ; 25(16): 5167-5176, 2019 08 15.
Article en En | MEDLINE | ID: mdl-31182435
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Proteínas Proto-Oncogénicas c-ets / Indoles / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Proteínas Proto-Oncogénicas c-ets / Indoles / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos